UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Emerging Fungal Threats in Cystic Fibrosis

Mycopathologia (1975), 2021-10, Vol.186 (5), p.639-653

2021

Volltextzugriff (PDF)

Pulmonary Aspergillosis in People with Cystic Fibrosis

Seminars in respiratory and critical care medicine, 2024-02, Vol.45 (1), p.128-140

2024

Volltextzugriff (PDF)

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders

Journal of cystic fibrosis, 2024-07, Vol.23 (4), p.590-602

2024

Volltextzugriff (PDF)

Respiratory Fungal Infections in Cystic Fibrosis: Diagnostic and Therapeutic Challenges

Current fungal infection reports, 2023-09, Vol.17 (3), p.202-213

2023

Volltextzugriff (PDF)

WS12.3 End-of-life-issues – a single-center retrospective analysis

Journal of cystic fibrosis, 2017-06, Vol.16, p.S21-S22

2017

Volltextzugriff (PDF)

P049 Tolerance induction (hyposensitisation) in drug intolerance to CFTR modulators

Journal of cystic fibrosis, 2021, Vol.20, p.S53

2021

Volltextzugriff (PDF)

P194 Severe pneumonia under therapy with CFTR modulators - a study of four cases and discussion of possible pathomechanisms

Journal of cystic fibrosis, 2020-06, Vol.19, p.S111-S111

2020

Volltextzugriff (PDF)

P301 Distal Intestinal Obstruction Syndrome (DIOS) – risk factors and complications. A single centre analysis

Journal of cystic fibrosis, 2024-06, Vol.23, p.S161-S161

2024

Volltextzugriff (PDF)

Update zur Therapie der CF bei Kindern und Jugendlichen

Pneumologe, 2022-03, Vol.19 (2), p.104-110

2022

Volltextzugriff (PDF)

EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2

Journal of cystic fibrosis, 2021, Vol.20, p.S36-S36

2021

Volltextzugriff (PDF)

P265 Fast-track biomarker “Anti-Exophiala IgG” in suspected Exophiala spp. infection

Journal of cystic fibrosis, 2023-06, Vol.22, p.S147-S147

2023

Volltextzugriff (PDF)

P392 Medical and mental status of refugees with cystic fibrosis from Ukraine

Journal of cystic fibrosis, 2023-06, Vol.22, p.S184-S184

2023

Volltextzugriff (PDF)

P443 Challenges of app-supported home monitoring for people with CF and the CF care team

Journal of cystic fibrosis, 2024-06, Vol.23, p.S203-S203

2024

Volltextzugriff (PDF)

WS12.2 Antigen-specific T cell response in Aspergillus fumigatus conditions in cystic fibrosis

Journal of cystic fibrosis, 2020-06, Vol.19, p.S20-S20

2020

Volltextzugriff (PDF)

WS04.04 Development and validation of the CFAbd-Score.kid, a novel gastrointestinal patient-reported outcome measure specific for children with cystic fibrosis

Journal of cystic fibrosis, 2024-06, Vol.23, p.S8-S8

2024

Volltextzugriff (PDF)

P051 Urban life as risk factor for aspergillosis

Journal of cystic fibrosis, 2020-06, Vol.19, p.S69-S69

2020

Volltextzugriff (PDF)

P148 Inhaled levofloxacin: impact of susceptibility testing results on FEV1 and exacerbation rate

Journal of cystic fibrosis, 2020-06, Vol.19, p.S97-S98

2020

Volltextzugriff (PDF)

P107 ECFS/CFF global survey on diagnosis and treatment of Aspergillus fumigatus-related conditions

Journal of cystic fibrosis, 2020-06, Vol.19, p.S85-S86

2020

Volltextzugriff (PDF)

P299 Assessing dynamics of abdominal symptoms during a new therapy with elexacaftor/tezacaftor/ivacaftor using the new CFAbd-day2day© questionnaire

Journal of cystic fibrosis, 2023-06, Vol.22, p.S156-S156

2023

Volltextzugriff (PDF)

WS02.01 Abdominal symptoms significantly decline after 24 weeks of elexacaftor/tezacaftor/ivacaftor treatment: first results obtained with the cystic fibrosis-specific CFAbd-Score in Germany and the UK

Journal of cystic fibrosis, 2022-06, Vol.21, p.S3

2022

Volltextzugriff (PDF)

P169 Longitudinal observation of azol-resistance Aspergillus fumigatus in patients with cystic fibrosis

Journal of cystic fibrosis, 2019-06, Vol.18, p.S105-S105

2019

Volltextzugriff (PDF)

WS17-1 Prospective evaluation of arthropathy in patients with cystic fibrosis

Journal of cystic fibrosis, 2019-06, Vol.18, p.S31-S32

2019

Volltextzugriff (PDF)

P165 Prospective evaluation of Aspergillus fumigatus-specific IgG in patients with cystic fibrosis

Journal of cystic fibrosis, 2019-06, Vol.18, p.S104-S104

2019

Volltextzugriff (PDF)

P093 Oral versus intravenous treatment of bronchopulmonary exacerbations in cystic fibrosis

Journal of cystic fibrosis, 2018-06, Vol.17, p.S85-S85

2018

Volltextzugriff (PDF)

P064 Clinical and immunological results of the Berlin Aspergillus Species Study (BASS)

Journal of cystic fibrosis, 2018-06, Vol.17, p.S77-S77

2018

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(108)
Deutsch
(2)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(50)
Humans
(37)
Animals
(33)
Cardiac & Cardiovascular Systems
(24)
Cardiovascular System & Cardiology
(24)
Male
(24)
Biological And Medical Sciences
(18)
Rats
(18)
Myocardial Contraction - Drug Effects
(15)
Adult
(13)
Medical Sciences
(13)
Female
(12)
Heart
(12)
Heart Failure
(12)
Myocardium - Metabolism
(12)
Cells, Cultured
(11)
Isoproterenol - Pharmacology
(10)
Cell Biology
(9)
Life Sciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Emerging Fungal Threats in Cystic Fibrosis

Pulmonary Aspergillosis in People with Cystic Fibrosis

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders

Respiratory Fungal Infections in Cystic Fibrosis: Diagnostic and Therapeutic Challenges

WS12.3 End-of-life-issues – a single-center retrospective analysis

P049 Tolerance induction (hyposensitisation) in drug intolerance to CFTR modulators

P194 Severe pneumonia under therapy with CFTR modulators - a study of four cases and discussion of possible pathomechanisms

P301 Distal Intestinal Obstruction Syndrome (DIOS) – risk factors and complications. A single centre analysis

Update zur Therapie der CF bei Kindern und Jugendlichen

EPS3.05 N-chlorotaurine is a very promising antiseptic treatment option for multiresistant bacteria, fungi and for viruses including SARS-CoV-2

P265 Fast-track biomarker “Anti-Exophiala IgG” in suspected Exophiala spp. infection

P392 Medical and mental status of refugees with cystic fibrosis from Ukraine

P443 Challenges of app-supported home monitoring for people with CF and the CF care team

WS12.2 Antigen-specific T cell response in Aspergillus fumigatus conditions in cystic fibrosis

WS04.04 Development and validation of the CFAbd-Score.kid, a novel gastrointestinal patient-reported outcome measure specific for children with cystic fibrosis

P051 Urban life as risk factor for aspergillosis

P148 Inhaled levofloxacin: impact of susceptibility testing results on FEV1 and exacerbation rate

P107 ECFS/CFF global survey on diagnosis and treatment of Aspergillus fumigatus-related conditions

P299 Assessing dynamics of abdominal symptoms during a new therapy with elexacaftor/tezacaftor/ivacaftor using the new CFAbd-day2day© questionnaire

WS02.01 Abdominal symptoms significantly decline after 24 weeks of elexacaftor/tezacaftor/ivacaftor treatment: first results obtained with the cystic fibrosis-specific CFAbd-Score in Germany and the UK

P169 Longitudinal observation of azol-resistance Aspergillus fumigatus in patients with cystic fibrosis

WS17-1 Prospective evaluation of arthropathy in patients with cystic fibrosis

P165 Prospective evaluation of Aspergillus fumigatus-specific IgG in patients with cystic fibrosis

P093 Oral versus intravenous treatment of bronchopulmonary exacerbations in cystic fibrosis

P064 Clinical and immunological results of the Berlin Aspergillus Species Study (BASS)

Suchergebnisse filtern